NYSE:DVAHealthcare
DaVita (DVA): Margin Decline Challenges Value Narratives as Shares Trade Below Fair Value
DaVita (DVA) reported earnings that are forecast to grow at 7.01% per year, with revenue expected to increase 4.3% annually. Both of these growth rates fall short of broader US market averages. The company’s net profit margin has slipped to 5.8%, down from 6.5% a year earlier, and over the last five years, its earnings have declined by 1.2% per year. Despite these pressures, DaVita’s high reported earnings quality and a share price of $118.75, which is well below the estimated fair value of...